Search Results for: Course relapse disease

April 6, 2019April 6, 2019

Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Publication date: Apr 04, 2019 Sodium (Na)-MRI is an emerging imaging technique to investigate in vivo changes in tissue viability, reflecting neuroaxonal integrity and metabolism. Using an optimised Na-MRI protocol ... Read more

November 28, 2019November 28, 2019

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease.

Melanoma Literature

Publication date: Nov 26, 2019 The introduction of new therapeutic agents has revolutionized the treatment of metastatic melanoma. The approval of adjuvant anti-PD-1 monotherapy with nivolumab or pembrolizumab and dabrafenib ... Read more

November 2, 2019November 2, 2019

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.

Multiple Sclerosis Literature

Publication date: Nov 01, 2019 Alemtuzumab is administered as two annual courses for relapsing-remitting multiple sclerosis (MS). Patients may relapse before completing the two-course regimen. The objective was to evaluate ... Read more

July 16, 2019July 16, 2019

Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in Children.

Multiple Sclerosis Literature

Publication date: Jul 15, 2019 Obesity reportedly increases the risk of pediatric multiple sclerosis (MS), but little is known about its association with disease course. To investigate the association of ... Read more

July 12, 2019July 12, 2019

Novel Management Strategies for MS Relapse

Multiple Sclerosis Media

Publication date: Jul 11, 2019 Experts consider novel strategies used to manage multiple sclerosis relapse, including repository corticotropin injection and plasma exchange. Concepts Keywords Algorithm Plasma exchange Arkham Multiple sclerosis ... Read more

June 8, 2019June 8, 2019

The course of stage III melanoma in accordance with the severity of node involvement.

Melanoma Literature

Publication date: Jun 06, 2019 Objectives: Pathological stage III melanoma patients have variable clinical presentation and outcome when divided by substages, and the number of metastatic lymph nodes is the ... Read more

May 31, 2019May 31, 2019

BG-12 and its potential for the prevention of relapse in multiple sclerosis.

Multiple Sclerosis Literature

Publication date: Mar 21, 2019 Multiple sclerosis (MS) arises from an immune attack on the central nervous system producing demyelination and axonal loss. Clinically the relapsing-remitting course is characterized by ... Read more

May 29, 2019May 29, 2019

Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis.

Multiple Sclerosis Literature

Publication date: May 25, 2019 Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system. The treatment of MS has always been a focus of neurological research. ... Read more

May 23, 2019May 23, 2019

Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab.

Multiple Sclerosis Literature

Publication date: May 22, 2019 Natalizumab is an efficacious disease modifying therapy (DMT) for relapsing remitting multiple sclerosis (RRMS), often limited by risk of progressive multifocal leukoencephalopathy. We describe the ... Read more

May 14, 2019May 14, 2019

Vitamin D genes influence MS relapses in children.

Multiple Sclerosis Literature

Publication date: May 13, 2019 The aim of this study was to determine whether a vitamin D genetic risk score (vitDGRS) is associated with 25-hydroxyvitamin D (25(OH)D) level and multiple ... Read more